XBOT — Realbotix Cashflow Statement
0.000.00%
- CA$114.11m
- CA$113.94m
- $1.28m
Annual cashflow statement for Realbotix, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 9 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.17 | -8.28 | -5.91 | -10.1 | -8.14 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -2.33 | 4.65 | 1.19 | 8.07 | 4.56 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.016 | 0.994 | -0.463 | 0.087 | -0.492 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.148 | -3.55 | -5 | -1.98 | -4.07 |
| Capital Expenditures | — | -1.6 | -0.005 | 0 | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -19.1 | 0 | -0.042 | 2.3 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -20.7 | -0.005 | -0.042 | 2.3 |
| Financing Cash Flow Items | — | — | 1.5 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 32 | 1.76 | -0.325 | -0.287 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.148 | 7.79 | -3.9 | -2.35 | -2.05 |